SECOND ANNOUNCEMENT Scientific Program Call for Abstracts Registration Accommodation Deadline for abstract submission: September 20 th, 2011 www.madridbreastcancer2011.com Madrid, November 16-17, 2011 Under the auspices of:
PRESIDENT G. Bonadonna (Milan) CHAIRMEN H. Cortés-Funes (Madrid) L. Gianni (Milan) SCIENTIFIC COMMITTEE C. Arteaga (Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tenessee, USA) J. Baselga (Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA) E. Ciruelos (Hospital Universitario 12 de Octubre, Madrid, Spain) H. Cortés-Funes (Hospital Universitario 12 de Octubre, Madrid, Spain) L. Gianni (Hospital San Raffaele del Monte Tabor, Milan, Italy) SCIENTIFIC SECRETARY E. Ciruelos (Hospital Universitario 12 de Octubre, Madrid, Spain) INVITED FACULTY E. Alba (Hospital Universitario Virgen de la Victoria, Málaga, Spain) C. Arteaga (Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tenessee, USA) J. Baselga (Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA) G. Calin (The University of Texas MD Anderson Cancer Center, Houston, Texas, USA) E. Ciruelos (Hospital Universitario 12 de Octubre, Madrid, Spain) R. Colomer (Institut Català d Oncologia, Hospital Universitari Dr. Josep Trueta, Gerona, Spain) J. Cortés (Hospital Universitario Vall d Hebron, Barcelona, Spain) H. Cortés-Funes (Hospital Universitario 12 de Octubre, Madrid, Spain) G. Curigliano (European Institute of Oncology, Milan, Italy) M. Dowsett (Royal Marsden Hospital, London, UK) M. Esteller (Institut d'investigació Biomèdica de Bellvitge, Barcelona, Spain) L. Gianni (Hospital San Raffaele del Monte Tabor, Milan, Italy) A. González (Centro Oncológico MD Anderson España, Madrid, Spain) P. Goodwin (Mount Sinai Hospital, Toronto, Canada) A. Llombart (Hospital Universitario Arnau de Vilanova, Lérida, Spain) A. Lluch (Hospital Clínico Universitario, Valencia, Spain) S. Loi (Institut Jules Bordet, Brussels, Belgium) R. Plummer (Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK) A. Prat (Lineberger Comprehensive Cancer Center, UNC School of Medicine, Chapel Hill, N. Carolina, USA) L. Pusztai (The University of Texas MD Anderson Cancer Center, Houston, Texas, USA) M. A. Quintela (Centro Nacional de Investigaciones Oncológicas, CNIO, Madrid, Spain) J. Reis-Filho (Breakthrough Research Center at The Institute of Cancer Research, London, UK) D. Silver (Dana-Farber Cancer Institute, Boston, Massachusetts, USA) J. P. Thiery (Institute of Molecular and Cell Biology, Singapore, Singapore) E. Winer (Dana-Farber Cancer Institute, Boston, Massachusetts, USA)
INVITATION Dear Colleagues, The IX MADRID BREAST CANCER CONFERENCE, will be held in Madrid, Spain, on November 16th-17th, 2011. Since 1995, this biennial conference has been a reference to all oncologists interested in the treatment of patients with breast cancer. And over 500 participants attend the Conference each time. Madrid Breast Cancer Conference is an integrated meeting focused on the most relevant and controversial topics on biology, diagnosis and treatment of breast cancer. Leaders in breast cancer research and treatment will actively participate in the Conference with cutting edge presentations, providing the most updated data and stimulating dialogue with participants and other invited speakers. The main objective of this Conference is to perform a comprehensive review on this disease and to carefully review the newest topics and controversial points. These contents will be divided in Plenary Lectures and Symposia. We look forward to seeing you in Madrid in November 2011! H. Cortés-Funes - L. Gianni Chairmen 3
Wednesday, November 16 2.45 pm Introduction Luca Gianni (Milan), Hernán Cortés-Funes (Madrid) 3.00-3.30 pm Opening Lecture Chairmen: Luca Gianni (Milan) Gene Pathways Associated with Prognosis and Chemotherapy Sensitivity in Different Molecular Subtypes Lajos Pusztai (Houston) 3.30-4.30 pm SYMPOSIUM I: Triple Negative Breast Cancer Chairmen: Daniel Silver (Boston), Javier Cortés (Barcelona) 3.30 pm Molecular Stratification of Triple-Negative Breast Cancers Aleix Prat (Chapel Hill) 3.50 pm PARP Inhibitors Development: Are We in the Right Direction? Ruth Plummer (Newcastle upon Tyne) 4.10 pm Discussion 4.30-5.00 pm Coffee-break 5.00-6.30 pm SYMPOSIUM II: Molecular Modifications on Breast Cancer Progression Chairmen: Lajos Pusztai (Houston), Miguel Ángel Quintela (Madrid) 5.00 pm Epithelial Mesenchymal Transition and Breast Cancer Progression Jean Paul Thiery (Singapore) 5.20 pm Epigenetic Changes on the Breast Cancer Development Manel Esteller (Barcelona) 5.40 pm Immunity and Autoimmunity in Breast Cancer Giuseppe Curigliano (Milan) 6.00 pm Discussion 6.30 pm Adjourn 4
Thursday, November 17 9.00-10.30 am SYMPOSIUM III: New Molecular Pathways Chairmen: Mitchell Dowsett (London), Emilio Alba (Málaga) 9.00 am Insuline Resistance: Relevance and Therapeutic Implications Pamela Goodwin (Toronto) 9.20 am PI3Kinase/mTOR Pathway: New Agents Carlos L. Arteaga (Nashville) 9.40 am DNA Repair and Breast Cancer: Therapeutic Opportunities Daniel Silver (Boston) 10.00 am Discussion 10.30-11.00 am Coffee-break 11.00-11.30 am Lecture Chairman: Eva Ciruelos (Madrid) Non-coding RNAs: The Role of micrornas in Breast Cancer. Therapeutic Implications George A. Calin (Houston) 11.30-1.00 pm SYMPOSIUM IV: HER2-positive Breast Cancer Chairmen: Antonio Llombart (Lérida), Ana Lluch (Valencia) 11.30 am New Clinical Approaches for the Neoadjuvant Systemic Therapy in HER2-positive Breast Cancer Luca Gianni (Milan) 11.50 am Anti-HER2 Targeted Therapies for Advanced Disease: Beyond Trastuzumab Eric Winer (Boston) 12.10 pm Biomarker Analysis for the Selection of anti-her2 Targeted Treatment: Ready for Its Use in the Clinic? José Baselga (Boston) 5
12.30 pm Discussion 1.00 pm Poster Discussion Ramón Colomer (Gerona) 1.30 pm Lunch 2.30-4.00 pm SYMPOSIUM V: Luminal Breast Cancer Chairmen: Carlos L. Arteaga (Nashville), Antonio González (Madrid) 2.30 pm Molecular Heterogeneity of Luminal Breast Cancer Sherene Loi (Brussels) 3.00 pm Translational Research and Strategies to Overcome Endocrine Resistance in Luminal Breast Cancer Mitchell Dowsett (London) 3.30 pm Discussion 4.00 pm Closing Lecture Chairman: Hernán Cortés-Funes (Madrid) 4.00 pm Interpretation and Molecular Validation of Biomarker Studies Jorge Reis-Filho (London) 4.30 pm Closing Remarks 6
PROGRAM SCHEDULE TIME WEDNESDAY NOVEMBER 16 TIME 9.00 am THURSDAY NOVEMBER 17 SYMPOSIUM III 10.30 am COFFEE-BREAK 11.00 am LECTURE 11.30 am SYMPOSIUM IV 1.00 pm POSTER DISCUSSION 1.30 pm LUNCH 2.00 pm REGISTRATION 2.30 pm SYMPOSIUM V 2.45 pm INTRODUCTION 4.00 pm CLOSING LECTURE 3.00 pm OPENING LECTURE 4.30 pm CLOSING REMARKS 3.30 pm SYMPOSIUM I 4.30 pm COFFEE-BREAK 5.00 pm SYMPOSIUM II 6.30 pm ADJOURN 7
GENERAL INFORMATION VENUE Fundación MMA Paseo de la Castellana, 33 28046 Madrid (Spain) CONFERENCE SECRETARIAT BN&Co. Congress and Event Management Paseo de la Castellana 179-5º B1 28046 MADRID - Spain Phone: +34 91 571 93 90 Fax: +34 91 571 92 06 E-mail: m.e.fernandez@bnyco.com CONFERENCE WEB www.madridbreastcancer2011.com CREDITS This Symposium is accredited by the European Society of Medical Oncology Continuing Education for its Medical Oncology Recertification Approval (ESMO/MORA) Program with 5 ESMO-MORA Category 1 points. LANGUAGE The official language of the Conference is English. There will be no translation. ABSTRACTS Authors interested in presenting data are requested to submit an abstract for Poster Presentation. Abstracts Deadline is September 20th, 2011. Accepted posters will be presented in Digital Screens. A modern digital system with tactile screens provides the continuous display of the posters as well as the individual view of the selected poster. The best poster will be awarded with 2.500. Poster authors should be registered in the Conference. TRANSPORT No transportation is foreseen from the airport to the Conferece or to the hotels. The underground station is next to the airport and taxis are very easily available at the airport. The selected hotels for the Symposium are at walking distance to the Conference Venue. CLOTHING Dress will be casual for all Conference events. INSURANCE The organisers will not be responsible for individual, medical, travel or personal insurance. Participants are advised to take out their own insurance policies. 8
NO SMOKING Smoking will be forbidden in all Conference areas. MOBILE PHONES Mobile phones must be disconnected during all the sessions. REGISTRATION a) Procedures By fax: Registration forms should be completed and sent by fax to the Secretariat. Information must be printed or typed. Your name should be written as you wish it to appear on your badge. Through the web: Registration form should be completed and sent following the web indications. b) Fees By July 15 th 2011 By November 1 st 2011 On site Registration ESMO/SOLTI/Michelangelo MEMBERS 400 a 450 a 550 a Non MEMBERS 500 a 600 a 700 a Physicians in Training 200 a 300 a 350 a Note. VAT included. Physicians in training should present a document signed by the Head of the Department. Registration includes entrance to all sessions, coffee-breaks, Welcome cocktail and lunch on Thursday, November 17 th. c) Payment All payments must be made in Euro to Fundación para la Investigación y Formación en Oncología by bank transfer or credit card. Personal, company or eurocheques are not accepted. d) Confirmation Registrations will be confirmed by e-mail, upon receipt of the registration fee. Please, present the confirmation at the Conference Registration desk to collect the documents. IMPORTANT: After November 1st no more advanced registrations will be accepted. All those wishing to register after that date are kindly requested to register directly on site. 9
e) Cancellation Notification of cancellation must be sent in writing to the Secretariat. Cancellations received by October 30th, 2011 will be reimbursed except 15% of handling fee. After this date no refunds will be made. ACCOMMODATION Hotel rooms have been booked for the Conference period in Hotel NH Abascal**** and Hotel HighTech Embassy****. Rooms will be allocated on a first come-first served basis. You will receive (by e-mail) written confirmation of your hotel booking, with full hotel address, which must be presented at the hotel upon arrival. Early reservation is advisable in order to arrange proper accommodation. Room rates nor room availability cannot be guaranteed after September 15 th, 2011. You can find information on official hotels in our web. a) Procedures By fax: Accommodation forms should be completed and sent by fax to the Secretariat. Information must be printed or typed. Through the web: Accommodation form should be completed and sent following the indications. HOTELS HOTEL SINGLE DOUBLE NH ABASCAL**** C/ José Abascal, 47 (15 min walking distance from Conference site) HIGH TECH EMBASSY**** C/ Serrano, 46 (11 min walking distance from Conference site) 114 a 126 a 156 a 168 a Prices are per room/night, including breakfast and VAT. b) Payment All payments must be made in Euro to: BENEANDCO, S.L., by bank transfer or credit card. Personal, company or eurocheques are not accepted. c) Confirmation Accommodation requests will be confirmed by e-mail, upon receipt of the payment. Please, keep this confirmation for your file. d) Cancellation Notification of cancellation must be sent in writing to the Secretariat. Cancellations received by September 15 th, 2011 will be reimbursed, except 15% of handling fee. No refunds can be made if notice of cancellation is received after this date. All refunds will be dealt after the Conference. 10
INSTRUCTIONS FOR THE PREPARATION AND SUBMISSION OF ABSTRACTS FOR POSTER PRESENTATION Participants with new data relevant to Breast Cancer may submit an abstract to be considered for Poster Presentation. The best poster will be awarded with 2.500. Content Abstracts must be written in English. They must describe in a succinct manner the purposes and results of the research. Each abstract should contain: an introductory sentence indicating the purposes of the study a brief description of pertinent experimental procedures a summary of the data a statement of conclusions Titles should be indicative of the content of the abstract. Avoid non standard abbreviations in abstract titles. Abbreviations may be used in the body of an abstract if they are defined at their first mention in the text. Abstract length and format The combined length of the abstract body and title should not exceed 300 words. Format is as follows: Abstract title (capital letters) Authors (please underline the name of presenting author) List affiliations after the authors list. Body: Purpose, Methods, Results, Conclusions Submission The accuracy of the submitted abstract is the responsibility of the authors. Abstracts will be published as submitted. They will not be corrected. Authors are requested to read abstracts carefully prior to submission. Abstracts should be submitted by e-mail to Encar Fernández: m.e.fernandez@bnyco.com before September 20th, 2011. Abstracts received after this date will not be considered. Corresponding author information Corresponding authors must provide their name, institution, address, city, country, telephone and fax numbers as well as e-mail. This author will receive all correspondence concerning the abstract. Confirmation and acceptance Confirmation of receipt, acceptance, provisional abstract number and all poster information will be sent to the corresponding author. Note: Only posters submitted by registered participants will be accepted. 11
12 IX MADRID BREAST CANCER CONFERENCE LATEST ADVANCES IN BREAST CANCER Madrid, November 16-17, 2011 REGISTRATION FORM Register on line at www.madridbreastcancer2011.com or complete this Registration Form (keep a copy for your file) and return it to the Secretariat: BN&Co. Congress and Event Management. Paseo de la Castellana 179-5º B1, 28046 Madrid. Phone 34 91 571 93 90 - Fax 34 91 571 92 06. E-mail: m.e.fernandez@bnyco.com Last Name... First Name... Department... Institute/Hospital... Address... Postal Code... City... Country... Telephone...Fax... E-mail... REGISTRATION FEES By July 15 th 2011 By November 1 st 2011 On site Registration ESMO/SOLTI/Michelangelo MEMBERS 400 a 450 a 550 a Non MEMBERS 500 a 600 a 700 a Physicians in Training 200 a 300 a 350 a Note. VAT included. Physicians in training should present a document signed by the Head of the Department. Registration includes entrance to all sessions, documents, coffee-breaks, Welcome cocktail and lunch on Thursday, November 17 th. Cancellations: Cancellations received by October 30 th, 2011 will be reimbursed, except 15% of handling fee. After this date no refunds will be made. Notification of cancellation must be sent in writing to the Secretariat. IMPORTANT: After November 1 st no more advanced registrations will be accepted. All those wishing to register after that date are kindly requested to register directly on site. Payment Payments should be made in Euro to: Fundación para la Investigación y Formación en Oncología By bank transfer to: Banco Santander Central Hispano. Account no. 0049-1803-56-2010306951 SWIFT: BSCHESMM Bank Address: Serrano 57 1ª planta - 28001 Madrid, Spain (Please enclose copy of payment with your registration form) By card: Eurocard Master Card Visa American Express Card no...cardholder s name... Expire date...signature... Please fill in for invoice purposes (Registration) Individual Company Name...Company Name... Address for invoice...address for invoice... Passport number...company VAT Number... Please remove my name from the mailing list (Directive 95/46 EC of the European Parliament and of the Council of 24 th October, 1995, on the protection of individuals with regard to the processing of personal data and on the free movement of those data).
IX MADRID BREAST CANCER CONFERENCE LATEST ADVANCES IN BREAST CANCER Madrid, November 16-17, 2011 HOTEL RESERVATION FORM Make your reservation on line at www.madridbreastcancer2011.com or complete this Reservation Form (keep a copy for your file) and return it to the Secretariat: BN&Co. Congress and Event Management. Paseo de la Castellana 179-5º B1, 28046 Madrid. Phone 34 91 571 93 90 - Fax 34 91 571 92 06. E-mail: m.e.fernandez@bnyco.com Last Name... First Name... Department... Institute/Hospital... Address... Postal Code... City... Country... Telephone...Fax... E-mail... HOTELS HOTEL SINGLE DOUBLE NH ABASCAL**** C/ José Abascal, 47 HIGH TECH EMBASSY**** C/ Serrano, 46 114 a 126 a 156 a 168 a Prices are per room/night, including breakfast and VAT. Cancellations received by September 15 th, 2011 will be reimbursed, except 15% of handling fee. No refunds can be made if notice of cancellation is received after this date. All refunds will be dealt after the Conference. Room rates nor room availability cannot be guaranteed after September 15 th, 2011. Hotel... No. Rooms... double/single...x...nights =...a Date of arrival...date of departure... Payment Payments should be made in Euro to: BENEANDCO, S.L. By bank transfer to: Banesto. Account no. 0030 8160 90 0000460271 SWIFT: ESPC-ESMM Bank Address: C/ Francisco Silvela, 53 nº 2-28028 Madrid (Please enclose copy of payment with your reservation form) By card: Eurocard Master Card Visa Card no...cardholder s name... Expire date...signature... Please fill in for invoice purposes (Accommodation) Individual Company Name...Company Name... Address for invoice...address for invoice... Passport number...company VAT Number... 13
A. NH ABASCAL HOTEL (C/ José Abascal, 47) B. CONFERENCE SITE: MUTUA MADRILEÑA (Paseo de la Castellana, 33) C. HIGH TECH EMBASSY HOTEL (C/ Serrano, 46)
Madrid, November 16-17, 2011
Madrid, November 16-17, 2011 CONFERENCE SECRETARIAT BN&Co. Congress and Event Management Paseo de la Castellana 179-5º B1 28046 MADRID - Spain Phone: +34 91 571 93 90 Fax: +34 91 571 92 06 E-mail: info@bnyco.com